Novo Nordisk shares rose in Copenhagen trading on Monday after the pharmaceutical giant reported on Sunday that its weight-loss drug Wegovy reduced the risk of heart attack, stroke, or death by 57% compared with tirzepatide, the active ingredient in Eli Lilly's Mounjaro and Zepbo...